Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000928475-04-000077
Filing Date
2004-11-22
Accepted
2004-11-22 15:29:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT 3 amendmentno3.txt SC 13D/A 11583
  Complete submission text file 0000928475-04-000077.txt   13810
Mailing Address 1500 CORPORATE DRIVE SUITE 400 CANONSBURG PA 15317
Business Address 1500 CORPORATE DRIVE SUITE 400 CANONSBURG PA 15317 724-514-1800
MYLAN LABORATORIES INC (Subject) CIK: 0000069499 (see all company filings)

EIN.: 251211621 | State of Incorp.: PA | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-10728 | Film No.: 041160616
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ICAHN ASSOCIATES CORP 767 FIFTH AVE #4700 NEW YORK NY 10153
Business Address C/O ICAHN ASSOCIATES CORP 767 FIFTH AVE #4700 NEW YORK NY 10153 2127024300
ICAHN CARL C ET AL (Filed by) CIK: 0000921669 (see all company filings)

EIN.: 000000000 | State of Incorp.: NY | Fiscal Year End: 1231
SIC: 0000